Skip to main content

Advertisement

Table 5 Selected publications on disease control rates following postoperative (n > 300) and definitive IMRT (n = 63) in OCC

From: Follow up after IMRT in oral cavity cancer: update

Author [ref] Center Year Interval N postop IMRT CT T3/4 N>/=2 lll/lV LRC D M F S O A S
Postop Definitive Postop Definitive Postop Definitive
Eisbruch et al [3] U of MI 2004 1997-2002 27 most postop na na na na 59% (3y) na na na na na
Yao et al [4] U of Iowa 2007 2001-05 55 49 (89%) 11% 56% 36% 91% 85% (3y) na 89% (3y) na 68% (3y) na
Studer et al [5] U of Zurich 2007 2002-07 58 28 (48%) 78% 69% 28% 62% 91% (2y) 43% (2y) 95% (2y) 85% (2y) 83% (2y) 30% (2y), n = 30
Gomez et al [12] MSKCC 2009 2000-06 35 35 (100%) 29% 40% 38% 80% 77% (3y) none 85% (3y) na 74% (3y) none
Chen WC et al [13] Chiayi, Taiwan 2009 2002-05 22 22 (100%) na na 7 (32%) 100% 64% (3y) none na na 67% (3y) none
Collan et al [14] U of Helsinki 2011 2001-2007 40 40 (100%) 38% na na na na none na na 75% (3y) none
Sher D et al [15] DFCI 2011 2004-09 42 30 (71%) ~76% 45% 30% 64% 91% (2y) 64% (2y) 94% (2y) 83% (2y) 85% (2y) 63% (2y), n = 12
Daly M et al [16] Stanford UMC 2011 2002-09 37 30 (81%) 68% 54% 46% 57% 53% (3y) 60% (3y) 81% (3y) 71% (3y) 60% (3y) 57% (3y), n = 7
own cohort U of Zurich 2012 2002-2011 160 99 (62%) 72% 40% 77% 68% 84% (4y) 40% (4y) 90% (4y) 85% (4y) 81% (4y) 38% (4y), n = 44
  1. (): included in the recent analysis.
  2. (): included all patients with R0-1 status (excluded 17 operated patients with macroscopic disease after surgery.
  3. U: University Hospital.
  4. MSKCC: Memorial Sloan-Kettering Cancer Center.
  5. DFCI: Dana-Farber Cancer institute.
  6. UMC: University Medical Center.
  7. CT: Chemotherapy.
  8. LRC: loco-regional control.
  9. DMFS: distant metastasis free survival.
  10. OAS: overall survival.